Hepato-Biliary and Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Center for Data Science, Yokohama City University, Yokohama, Japan.
Ann Surg. 2021 Feb 1;273(2):224-231. doi: 10.1097/SLA.0000000000004051.
To assess the clinical impact of a no-drain policy after hepatic resection.
Previous randomized controlled trials addressing no-drain policy after hepatic resection seem inconclusive because they did not adopt appropriate study design to validate its true clinical impact.
This unblinded, randomized controlled trial was done at 7 Japanese institutions. Patients undergoing hepatic resection without biliary reconstruction were randomized to either D group or ND group. When the risk of postoperative bile leakage or hemorrhage were considered high, the patients were excluded during the operation. Primary endpoint was the postoperative complication of C-D grade 3 or higher within 90 postoperative days. A noninferiority of ND group to D group was assessed, and if it was confirmed, a superiority was assessed.
Between May 2015 and July 2017, a total of 400 patients were finally included in the per-protocol set analysis: 199 patients in D group and 201 patients in ND group. Intraoperatively, 37 patients were excluded from the final enrollment because of high risk of bile leakage or hemorrhage. Postoperative complication rate of C-D grade 3 or higher was 8.0% (16/199) in the D group and 2.5% (5/201) in the ND group. The risk difference was -5.5% (95% confidence interval: -9.9% to -1.2%) and fulfilled the prescribed noninferiority margin of 4%. No postoperative mortality was experienced in both groups. Bile leakage was diagnosed in 8.0% (16/199) of the D group and none in the ND group (P < 0.001). In none of the subgroups classified based on 8 potentially relevant factors, drain placement was favored in terms of C-D grade 3 or higher complication.
Drains should not be placed after uncomplicated hepatic resections.
评估肝切除术后不引流策略的临床影响。
先前探讨肝切除术后不引流策略的随机对照试验结果似乎并不明确,因为它们没有采用适当的研究设计来验证其真实的临床影响。
本非盲、随机对照试验在日本的 7 家机构进行。接受无胆道重建肝切除术的患者被随机分配至 D 组或 ND 组。如果认为术后胆漏或出血的风险较高,则在手术过程中排除这些患者。主要终点是术后 90 天内 C-D 分级 3 级或更高的术后并发症。评估 ND 组与 D 组相比的非劣效性,如果得到确认,则进一步评估其优越性。
2015 年 5 月至 2017 年 7 月,共有 400 例患者最终纳入意向治疗集分析:D 组 199 例,ND 组 201 例。术中因胆漏或出血风险高而有 37 例患者被排除最终入组。D 组 C-D 分级 3 级或更高的术后并发症发生率为 8.0%(16/199),ND 组为 2.5%(5/201)。风险差为-5.5%(95%置信区间:-9.9%至-1.2%),符合规定的 4%非劣效性边界。两组均无术后死亡病例。D 组有 8.0%(16/199)诊断为胆漏,ND 组无胆漏(P<0.001)。在基于 8 个潜在相关因素分类的所有亚组中,在 C-D 分级 3 级或更高的并发症方面,引流放置并不占优势。
对于无并发症的肝切除术,不应放置引流管。